Filing Details

Accession Number:
0001437749-19-023469
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-11-22 16:42:11
Reporting Period:
2019-11-20
Accepted Time:
2019-11-22 16:42:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1158895 Lemaitre Vascular Inc LMAT Surgical & Medical Instruments & Apparatus (3841) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1365733 Jr P Joseph Pellegrino C/O Lemaitre Vascular, Inc.
63 Second Avenue
Burlington MA 01803
Chief Financial Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-11-20 11,182 $7.87 184,054 No 4 M Direct
Common Stock Disposition 2019-11-20 11,182 $35.01 172,872 No 4 S Direct
Common Stock Acquisiton 2019-11-21 5,745 $7.87 178,617 No 4 M Direct
Common Stock Disposition 2019-11-21 5,745 $35.01 172,872 No 4 S Direct
Common Stock Acquisiton 2019-11-22 25,945 $7.87 198,817 No 4 M Direct
Common Stock Disposition 2019-11-22 25,945 $35.09 172,872 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2019-11-20 11,182 $0.00 11,182 $7.87
Common Stock Stock Option (Right to Buy) Disposition 2019-11-21 5,745 $0.00 5,745 $7.87
Common Stock Stock Option (Right to Buy) Disposition 2019-11-22 25,945 $0.00 25,945 $7.87
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
31,690 2014-07-24 2021-07-24 No 4 M Direct
25,945 2014-07-24 2021-07-24 No 4 M Direct
0 2014-07-24 2021-07-24 No 4 M Direct
Footnotes
  1. Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
  2. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $35.00 to $35.07. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  3. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $35.00 to $35.08. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  4. The price reported in Column 4 is a weighted average price. The transaction was executed in multiple trades ranging from $35.00 to $35.34. The reporting person undertakes to provide to the issuer, any securityholder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares and price at which the transaction was effected.
  5. This option is fully vested and exercisable.